Assignee
CUBIST PHARM INC
US·50 granted patents·30 pending applications·1,045 citations·filing 1994–2015
Top patents by PatentIndex Score
80 records- 0195US8476425B1Tazobactam arginine compositionsCUBIST PHARM INC·Filed 2012·Granted Jul 2, 2013·19 cites·3 claims
- 0293US8809314B1Cephalosporin compoundCUBIST PHARM INC·Filed 2013·Granted Aug 19, 2014·16 cites·7 claims
- 0392US9320740B2Ceftolozane-tazobactam pharmaceutical compositionsCUBIST PHARM INC·Filed 2014·Granted Apr 26, 2016·8 cites·21 claims
- 0492US6696412B1High purity lipopeptides, Lipopeptide micelles and processes for preparing sameCUBIST PHARM INC·Filed 2000·Granted Feb 24, 2004·46 cites·56 claims
- 0590US7527807B2Compositions and methods for increasing the oral absorption of antimicrobialsCUBIST PHARM INC·Filed 2001·Granted May 5, 2009·31 cites·12 claims
- 0689US8846610B2Methods for preparing purified lipopeptidesCUBIST PHARM INC·Filed 2013·Granted Sep 30, 2014·4 cites·20 claims
- 0788US8962843B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·3 cites·5 claims
- 0888US7335725B2Lipopeptides as antibacterial agentsCUBIST PHARM INC·Filed 2005·Granted Feb 26, 2008·16 cites·28 claims
- 0988US6794490B2Lipopeptides as antibacterial agentsCUBIST PHARM INC·Filed 2000·Granted Sep 21, 2004·45 cites·26 claims
- 1087US7262268B2Lipopeptide stereoisomers, methods for preparing same, and useful intermediatesCUBIST PHARM INC·Filed 2002·Granted Aug 28, 2007·13 cites·7 claims
- 1187US5798240ARecombinant mycobacterial methionyl-tRNA synthetase genes and methods of use thereforeCUBIST PHARM INC·Filed 1996·Granted Aug 25, 1998·84 cites·62 claims
- 1287US5759833AHuman isoleucyl-tRNA synthetase proteins, nucleic acids and tester strains comprising sameCUBIST PHARM INC·Filed 1995·Granted Jun 2, 1998·93 cites·21 claims
- 1387US5756327ARecombinant mycobacterial isoleucyl-tRNA synthetase genes, tester strains and assaysCUBIST PHARM INC·Filed 1995·Granted May 26, 1998·85 cites·28 claims
- 1486US8916709B21,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Dec 23, 2014·4 cites·20 claims
- 1586US5801013AHelicobacter aminoacyl-tRNA synthetase proteins, nucleic acids and strains comprising sameCUBIST PHARM INC·Filed 1995·Granted Sep 1, 1998·88 cites·63 claims
- 1685US9006421B2Cephalosporin compositions and methods of manufactureCUBIST PHARM INC·Filed 2014·Granted Apr 14, 2015·6 cites·16 claims
- 1785US8853357B2High purity lipopeptidesCUBIST PHARM INC·Filed 2013·Granted Oct 7, 2014·5 cites·11 claims
- 1884US9120795B2Crystalline form of a β-lactamase inhibitorCUBIST PHARM INC·Filed 2014·Granted Sep 1, 2015·5 cites·20 claims
- 1984US6852689B2Methods for administration of antibioticsCUBIST PHARM INC·Filed 2002·Granted Feb 8, 2005·26 cites·57 claims
- 2084US6468967B1Methods for administration of antibioticsCUBIST PHARM INC·Filed 1999·Granted Oct 22, 2002·65 cites·45 claims
- 2183US8969570B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Mar 3, 2015·3 cites·15 claims
- 2283US6475726B1Method for identifying validated target and assay combinations for drug developmentCUBIST PHARM INC·Filed 1999·Granted Nov 5, 2002·68 cites·9 claims
- 2382US8940897B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 27, 2015·1 cites·5 claims
- 2482US8933233B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 2582US8933232B21,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 13, 2015·1 cites·5 claims
- 2682US8927724B2Isoxazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Jan 6, 2015·3 cites·39 claims
- 2782US8796224B2Methods for preparing purified lipopeptidesCUBIST PHARM INC·Filed 2013·Granted Aug 5, 2014·2 cites·18 claims
- 2882US5885815ACandida isoleucyl-tRNA synthetase proteins, nucleic acids and strains comprising sameCUBIST PHARM INC·Filed 1996·Granted Mar 23, 1999·73 cites·51 claims
- 2981US9138456B2Lipopeptide compositions and related methodsCUBIST PHARM INC·Filed 2013·Granted Sep 22, 2015·6 cites·15 claims
- 3081US8962844B21,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitorsCUBIST PHARM INC·Filed 2013·Granted Feb 24, 2015·1 cites·5 claims
- 3181US7335726B2Lipopeptide stereoisomers, methods for preparing same and useful intermediatesCUBIST PHARM INC·Filed 2006·Granted Feb 26, 2008·4 cites·3 claims
- 3280US9193729B2Inhibiting transient receptor potential ion channel TRPA1CUBIST PHARM INC·Filed 2013·Granted Nov 24, 2015·6 cites·11 claims
- 3380US8003673B2Daptomycin for the treatment of biofilm and catheter salvageCUBIST PHARM INC·Filed 2006·Granted Aug 23, 2011·17 cites·20 claims
- 3480US6911525B2Lipopeptides as antibacterial agentsCUBIST PHARM INC·Filed 2000·Granted Jun 28, 2005·15 cites·31 claims
- 3578US6436694B1Regulable gene expression in gram-positive bacteriaCUBIST PHARM INC·Filed 1999·Granted Aug 20, 2002·34 cites·31 claims
- 3676US5726195AAminoacyl adenylate mimics as novel antimicrobial and antiparasitic agentsCUBIST PHARM INC·Filed 1996·Granted Mar 10, 1998·21 cites·50 claims
- 3772US6221640B1Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising sameCUBIST PHARM INC·Filed 1997·Granted Apr 24, 2001·42 cites·110 claims
- 3872US2015031659A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 3971US7408025B2Lipopeptides as antibacterial agentsCUBIST PHARM INC·Filed 2000·Granted Aug 5, 2008·5 cites·30 claims
- 4070US5824657AAminoacyl sulfamides for the treatment of hyperproliferative disordersCUBIST PHARM INC·Filed 1997·Granted Oct 20, 1998·25 cites·19 claims
- 4168US2015031665A11,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4267US2015183830A1Methods for preparing purified lipopeptidesCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4367US2015031666A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4467US2015038478A1Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4566US9108966B2Beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Granted Aug 18, 2015·0 cites·3 claims
- 4664US2015031660A11,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitorsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4763US2014274992A1Ceftolozane pharmaceutical compositionsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 4863US2008154514A1System and method for selectively classifying a populationCUBIST PHARM INC·Filed 2007·Application pending·0 cites
- 4963US2014274989A1Manufacturing beta-lactam combination productsCUBIST PHARM INC·Filed 2014·Application pending·0 cites
- 5063US2014274994A1Stabilizing ceftolozaneCUBIST PHARM INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CUBIST PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →